4//SEC Filing
Sandoval Elisabeth 4
Accession 0001209191-23-058813
CIK 0001566044other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:06 PM ET
Size
5.8 KB
Accession
0001209191-23-058813
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Option (right to buy)
2023-12-13+20,000→ 20,000 totalExercise: $2.70Exp: 2033-12-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001632295
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:06 PM ET
- Size
- 5.8 KB